Alumis Inc. Common Stock

ALMSNASDAQUSD
23.62 USD
0.34 (1.42%)AT CLOSE (11:59 AM EDT)
24.00
0.38 (1.60%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
24.00
0.38 (1.60%)
🔴Market: CLOSED

Shares of Alumis Inc. Common Stock (ALMS) are trading at $23.64. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Aug 26, 2026.

Open?$24.14
High?$24.14
Low?$23.16
Prev. Close?$23.96
Volume?642.6K
Avg. Volume?926.8K
VWAP?$23.76
Rel. Volume?0.69x
Bid / Ask
Bid?$19.59 × 100
Ask?$27.52 × 100
Spread?$7.93
Midpoint?$23.56
Valuation & Ratios
Market Cap?3.1B
Shares Out?129.4M
Float?74.5M
Float %?60.4%
P/E Ratio?N/A
P/B Ratio?6.86
EPS?-$3.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
Employees
239
Market Cap
3.1B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-06-28
Address
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
100
Momentum?
10
Short Sent.?
54
Piotroski F-Score?1/9Weak
Altman Z-Score?12.57Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?7.86%Elevated
Short Interest?5.9M
Days to Cover?6.5
Free Float74.5M
Avg Daily Volume897.6K
Settlement Date2026-08-14
Financial Health
Current Ratio?6.74Strong
Quick Ratio?6.74Strong
Cash Ratio?0.84Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A
P/B?
Peers
100
S&P
27
6.86FAIR
P/S?
Peers
100
S&P
3
419.20HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-7.3CHEAP
EV/Sales?
Peers
100
S&P
3
410.59HIGH
Returns & Efficiency
ROE?
S&P
3
-97.1%WEAK
ROA?
S&P
3
-78.3%WEAK
Cash Flow & Enterprise
FCF?$-351799000
Enterprise Value?$3.0B
Fundamentals ratios updated end of day